Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Eduardo Gomez is looking for contech partners. As head of CRH Ventures, the contech investment arm of Dublin-based building materials firm CRH, Gomez is seeking founders who want to partner and work together to get to market. […]
Circularity, sustainability provide opportunities: VC lead Read More »
Danaher shares are under pressure Wednesday as the Club holding’s fourth-quarter earnings results came in mixed and guidance disappointed. The company long known for its operational excellence is further testing our patience. Revenue for the three months ended Dec. 31 advanced 2% year over year on a reported basis, to $6.54 billion, outpacing the LSEG
We're cutting our price target on Danaher as frustration mounts after a messy quarter Read More »
New York-based brand management company American Exchange Group (AXNY) has acquired Urban Skin Rx, a clinical skin care brand specializing in bringing “hyperpigmentation and skin care expertise for deeper skin tones to the mass market,” according to the company’s website. The acquisition builds on AXNY Group’s efforts to expand its footprint in the beauty and
AXNY Group strengthens beauty portfolio with Urban Skin Rx acquisition Read More »
Organic feminine care and reproductive wellness brand LOLA has launched its first postpartum care line. According to the company’s website, the brand was “created to address the need for more transparency in women’s health.” LOLA’s current product offerings include period care, sexual wellness, and vaginal care, and the postpartum care line expansion reflects the company’s
LOLA expands into postpartum care with products for modern moms Read More »
Healthy aging and longevity took center stage at the recent Openstreams Global Beauty Industry Summit, held for the first time at the United Nations Headquarters in New York City last month. Organized by the nonprofit arm of the beauty industry data insight platform BEAUTYSTREAMS, the event brought together thought leaders, innovators, and professionals from the
Insights from Openstreams’ Global Beauty Industry Summit: The Aging Forum Read More »
Verizon Connect’s Extended View Cameras expand its Integrated Video platform, featuring four additional cameras and an in-cab monitor. Verizon Connect recently launched its new Extended View Cameras and Driver Vehicle Inspection Report (DVIR) to enhance commercial fleet safety, driver performance, and operational efficiency. The Extended View Cameras deliver near-360-degree visibility with
New Verizon Connect Tools Aim to Reduce Blind Spots, Cut Accident Risks Read More »
President Donald Trump signed a broad executive order targeting transition-related medical care for minors Tuesday. The order, titled “Protecting Children From Chemical and Surgical Mutilation,” intends to restrict access to gender-affirming medical care â including puberty blockers, hormone therapy and surgery â for minors, which it defines as those younger than 19. It prohibits federal
Trump signs sweeping order to further restrict trans care for minors nationwide Read More »
Embattled genetic testing company 23andMe said on Tuesday that it’s started exploring strategic alternatives for a second time, which could include a sale of the company or its assets, a restructuring or a business combination. The stock, which lost 82% of its value last year, fell 10% in extended trading and was briefly halted. The
23andMe is exploring strategic alternatives, looking to raise capital Read More »
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. President Donald Trump kicked off the first week of his second term with sweeping changes to U.S. health care and federal health agencies. Here are a few
Healthy Returns: Trump made sweeping changes to health care in his first week Read More »
The Food and Drug Administration on Tuesday approved Novo Nordisk‘s Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular injection in the U.S. The drug is already widely used and covered to treat Type 2 diabetes. The FDA’s decision means Ozempic can now
